To see a world free of dementia.
To fund the discovery of breakthrough drugs and novel treatments to eliminate dementia.
Clear Thoughts Foundation (CTF), established in 2010, is a nonprofit organization located in Pittsburgh PA. Our primary purpose is to raise funds to discover breakthrough drugs and novel treatments to stop the progression of dementia and eventually eliminate this terrible disease. All of the founding members of CTF have had some personal experience with dementia, such as Alzheimer’s disease and FTD. All of them are disappointed with the lack of available and effective drugs and therapeutics in today’s market.
The timing is right for you to join our fight against dementia! Dementia is a fast growing problem, not only in the United States, but globally, affecting billions of people – with that number growing higher daily and inflicting many at a much younger age. We have the connections, the energy, and the backgrounds to make an immediate effect, as we are surrounded in Pittsburgh by a wealth of outstanding health organizations. This offers us relative ease in accessing a very talented scientific community making our organization well positioned to tap into a wealth of novel scientific ideas and discoveries. Now all we need is YOU!
Our Guiding Creed
Funding is our barrier. Awareness is our opportunity. Research is our salvation.
Time is our enemy. YOU are our hope.
What Makes Us Different?
Clear Thoughts Foundation has pledged to take a stand in funding research to fight against all forms of dementia, in contrast to the majority of charitable causes that focus their efforts on targeting a specific dementia disease. While many philanthropic organizations give support for basic research into the causes of the disease; few focus on both breakthrough drug discovery and development of novel treatments (bio-genetics, stem cells, etc.).
Our Board & Staff Members
We are a diverse, yet passionate group of individuals who share the common thread of having our lives touched by personal experiences with dementia. We know firsthand the frustration and disappointment of limited treatments, inadequate drugs, and lack of funding to aggressively treat this fast growing, consuming and heart wrenching disease. Hear the stories behind the faces of our CTF team.
Hayley D. Jameson
D. Matthew Jameson III
Karl Herrup, Ph.D.
Robert “Bobby” Ward
James L. Cook III